Michele Schraeder
Optometrist · Pittsburgh, PANPI 1346577301
Payments from drug & device makers
Across 116 payments — averaging $26.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$712
- Sun Pharmaceutical Industries Inc.$366
- Johnson & Johnson Vision Care, Inc.$338
- Novartis$269
- Alcon$253
- Oyster Point Pharma, Inc.$243
- plus $906 from 14 others
What the payments were for
- Food & beverage$3,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 25 | $712 |
| Sun Pharmaceutical Industries Inc. | 17 | $366 |
| Johnson & Johnson Vision Care, Inc. | 11 | $338 |
| Novartis | 15 | $269 |
| Alcon | 8 | $253 |
| Oyster Point Pharma, Inc. | 8 | $243 |
| Amgen | 3 | $159 |
| Coopervision Inc. | 6 | $133 |
| Biotissue Holdings Inc. | 1 | $122 |
| Harrow Eye, LLC | 4 | $99 |
| Tarsus Pharmaceuticals, Inc. | 3 | $80 |
| Kala Pharmaceuticals, Inc. | 3 | $60 |
| AbbVie(2 entities) | 2 | $45 |
| Thea Pharma Inc. | 2 | $38 |
| Aerie Pharmaceuticals, Inc. | 2 | $35 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $31 |
| Glaukos Corporation | 1 | $29 |
| ABB Con-cise Optical Group LLC | 1 | $28 |
| Dompe US, Inc. | 1 | $26 |
| Ivantis, Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MIEBO$319
- XIIDRA$218
- Acuvue$171
- INFUSE$124
- TEPEZZA$123
- Prokera$122
- AmnioGraft$122
- AmnioGuard$122
- TRYPTYR$117
How this compares
$3,087 in reported general payments places this provider in the 85th percentile of 2,165 optometrist providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MieboPerfluorohexyloctane/Pf | 18 | $21,066 |
| RestasisCyclosporine | 12 | $18,027 |
| Cyclosporine | 12 | $10,038 |
| Doxycycline Hyclate | 19 | $373 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Miebo | $712 | $21,06618 claims |
| AbbVieRestasis | $45 | $18,02712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,165 optometrist providers in Pennsylvania.
Other optometrist in Pittsburgh
- Erick HendersonPittsburgh$266K
- William Vincett JrPittsburgh$57K
- Joshua ClermontPittsburgh$24K
- Jane ManlyPittsburgh$13K
- Mark ClementPittsburgh$11K
- James DeomHazle Township$793K
- Gregory CaldwellDuncansville$547K
- Glenn CorbinWyomissing$426K
- Leslie O DellNew Freedom$409K
- Kevin BistlinePlymouth Meeting$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.